Back
Results - Announcements
Sales decline 6.92% to Rs 41.14 crore
Medicamen Biotech standalone net profit declines 9.03% in the December 2024 quarter
11-Feb-2025, 05:42
Net profit of Medicamen Biotech declined 9.03% to Rs 2.52 crore in the quarter ended December 2024 as against Rs 2.77 crore during the previous quarter ended December 2023. Sales declined 6.92% to Rs 41.14 crore in the quarter ended December 2024 as against Rs 44.20 crore during the previous quarter ended December 2023.
Net profit of Medicamen Biotech declined 9.03% to Rs 2.52 crore in the quarter ended December 2024 as against Rs 2.77 crore during the previous quarter ended December 2023. Sales declined 6.92% to Rs 41.14 crore in the quarter ended December 2024 as against Rs 44.20 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 41.14 | 44.20 | -7 |
| OPM % | 15.17 | 12.67 | - |
| PBDT | 5.65 | 5.78 | -2 |
| PBT | 3.48 | 4.02 | -13 |
| NP | 2.52 | 2.77 | -9 |
Powered by Capital Market - Live News